ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement Press release LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 25, 2024
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. September 28, 2023
ProQR Announces Expert Perspectives Conference Call Series Press release Initial call in the series will feature Usher syndrome and retinitis pigmentosa on June 22 June 12, 2020
ProQR Therapeutics Provides Update on Ophthalmic Assets Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 27, 2023
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day Press release LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. January 29, 2019